Global Oncology Academy
Popular
Brian P. McDonough, MD, FAAFP
Urs Weber, MD
Hallie Blevins, PhD
Marlene Mimi Maeusli, PhD.
Brian P. McDonough, MD, FAAFP
Doris M. Ponce, MD, MS
- Project Oncology®
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Steve Jackson, PharmD
Raghava Reddy Induru, MD
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Brian P. McDonough, MD, FAAFP
Bilal Siddiqui, MD
Natalia Usoltseva MD, FACP, MHA
Medical News
- 05/22/2026
- 05/19/2026
- 05/18/2026
- 05/18/2026
CME/CE
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
- MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC
1.00 program creditBenjamin Levy, MD
Melin Khandekar, MD, PhD
- MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
1.00 program creditBarbara O'Brien, MD
Nadia Harbeck, MD, PhD
Barbara O'Brien, MD
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Nadia Harbeck, MD, PhD
Clinical Practice
Hallie Blevins, PhD
Marlene Mimi Maeusli, PhD.
- Project Oncology®
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Charles Turck, PharmD, BCPS, BCCCP
Daniel Geynisman, MD
Jonathan Henderson, MD
Steve Jackson, PharmD
Matthew J. Matasar, MD
Tycel Phillips, MD
Natalia Usoltseva MD, FACP, MHA
Programs
Gates B. Colbert, MD
Sarina Schrager, MD
Lashika Yogendran, MD
- Project Oncology®
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Charles Turck, PharmD, BCPS, BCCCP
Daniel Geynisman, MD
Jonathan Henderson, MD
Natalia Usoltseva MD, FACP, MHA
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD